Regeneron Pharmaceuticals | REGN - Market Capitalization

Stock Price
745.77
Daily Change
-0.84 -0.11%
Monthly
-6.02%
Yearly
11.83%
Q1 Forecast
723.25

Regeneron Pharmaceuticals reported $81.8B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 40M 24M Mar/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Kyowa Hakko Kirin JPY 1.33T 120.11B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 246.07B 11.81B Sep/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 117.34B 2.45B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025